Flamel Technologies is a specialty pharmaceutical company with a long history of expertise in drug delivery, focusing on the development of safer and more efficacious formulations, tackling unmet medical needs in the process.
Controlled release of injected biologics and small molecules drugs.
Controlled release oral liquid drugs.
Controlled release of oral drugs.
Tamper-resistant controlled release formulations of narcotics and other drugs prone to abuse.
Enhanced formulation of vaccines.
Flamel Technologies has an active licensing program and is proactively seeking partners with either small or large molecules for its drug delivery technologies.
As a publicly-held company, Flamel Technologies strives to use its technologies to create extraordinary shareholder value.